Photodynamic therapy in treatment of squamous cell carcinoma of oral cavity with chlorine e6 photosensitizer with long-term follow up

Author:

Panaseykin Y. A.1,Kapinus V. N.1,Filonenko E. V.2,Polkin V. V.1,Sevrukov F. E.1,Smirnova M. A.3,Isaev P. A.1,Ivanov S. A.4,Kaprin A. D.5

Affiliation:

1. A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation

2. P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation

3. Obninsk Institute for Nuclear Power Engineering

4. A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation; Peoples Friendship University of Russia (RUDN University)

5. P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation; Peoples Friendship University of Russia (RUDN University); National Medical Research Radiological Center of the Ministry of Health of the Russian Federation

Abstract

Photodynamic therapy is an effective method for treating superficial forms of malignant neoplasms, characterized by a minimal risk of damage to normal tissues. In this study, we presented our experience of treating cancer of the oral mucosa using photodynamic therapy, and analyzed the immediate and long-term results of treatment. 38 patients with squamous cell carcinoma of oral cavity mucosa, with a depth of invasion no more than 7 mm, were included in the study. All patients underwent photodynamic therapy with chlorine e6 based photosensitizer. Photosensitizers were administered intravenously 3 hours before irradiation, at a dosage of 1 mg/kg of the patient’s weight. Photodynamic therapy was performed with the following parameters: P – 1.0 W, Ps – 0.31 W/cm2, E – 300 J/cm2. The area of one irradiation field ranged 1.0-2.0 cm2. Treatment effect was evaluated by RECIST 1.1. Overall survival, cancer-specific survival, and disease-free survival were calculated using Kaplan-Meier curves. Evaluation of adverse events was made by .TCAE 5.0 criteria. At 35 (92.1%) out of 38 cases, complete regression was observed after photodynamic therapy. Among them in 3 out of 35 patients relapse was diagnosed in 11.5 to 43.2 months. The total number of patients who didn’t respond to treatment was 6 (15.8%). Follow-up period was 4.2-87.3 months. (mean 42.9). 34 (89.5%) out of 38 patients are alive, 1 (2.6%) died from progression, and three died from other causes. The 5-year overall survival rate was 82.1%, cancer-specific survival rate was 97.0%, and disease-free survival rate was 81.1%. Among the factors significantly (p < 0.05) influencing relapse-free survival: depth of invasion < 5 mm (p – 0.013) and the presence of leukoplakia (p – 0.007). When assessing cancer-specific survival, factors worsening the prognosis were: age >70 years (p – 0.034) and the presence of leukoplakia (p – 0.007). Photodynamic therapy is an alternative treatment method of oral cancer superficial lesions, in case of proper assessment of primary lesion and in case of possibility of full irradiation of the tumor. Moreover, after using photodynamic therapy, the underlying connective-muscular structures are preserved, which promotes rapid healing with minimal scarring, the functions of the affected organ remain intact, and cosmetic defects do not form.

Publisher

Russian Photodynamic Association

Reference40 articles.

1. Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Clinical recommendations of the Association of Oncologists of Russia. Malignant neoplasms of the oral cavity, 2020, pp. 18-19

2. Cooper J.S., Zhang Q., Pajak T.F., et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys, 2012, vol. 84(5), pp. 1198-205.

3. Kansy K., Mueller A.A., Mücke T., et al. A worldwide comparison of the management of T1 and T2 anterior floor of the mouth and tongue squamous cell carcinoma Extent of surgical resection and reconstructive measures. J. Craniomaxillofac Surg, 2017, vol. 45(12), pp. 2097-2104.

4. Ochoa E., Larson A.R., Han M., et al. Patient-Reported Quality of Life After Resection With Primary Closure for Oral Tongue Carcinoma. Laryngoscope, 2021, vol. 131(2), pp. 312-318.

5. Biazevic M.G., Antunes J.L., Togni J., et al. Immediate impact of primary surgery on health-related quality of life of hospitalized patients with oral and oropharyngeal cancer. J. Oral Maxillofac Surg, 2008, vol. 66, pp. 1343-1350.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3